Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

MSW vs CANG vs AUTL vs CLPS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MSW
Ming Shing Group Holdings Limited

Engineering & Construction

IndustrialsNASDAQ • HK
Market Cap$25M
5Y Perf.-71.6%
CANG
Cango Inc.

Auto - Dealerships

Consumer CyclicalNYSE • CN
Market Cap$250M
5Y Perf.-68.5%
AUTL
Autolus Therapeutics plc

Biotechnology

HealthcareNASDAQ • GB
Market Cap$410M
5Y Perf.-52.7%
CLPS
CLPS Incorporation

Information Technology Services

TechnologyNASDAQ • HK
Market Cap$25M
5Y Perf.-18.9%

MSW vs CANG vs AUTL vs CLPS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MSW logoMSW
CANG logoCANG
AUTL logoAUTL
CLPS logoCLPS
IndustryEngineering & ConstructionAuto - DealershipsBiotechnologyInformation Technology Services
Market Cap$25M$250M$410M$25M
Revenue (TTM)$34M$3.46B$51M$299M
Net Income (TTM)$-6M$-178M$-225M$-4M
Gross Margin-3.9%13.6%-309.4%22.8%
Operating Margin-15.8%7.3%-8.6%-1.4%
Forward P/E5.7x
Total Debt$8M$170M$53M$34M
Cash & Equiv.$250K$1.29B$227M$28M

MSW vs CANG vs AUTL vs CLPSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MSW
CANG
AUTL
CLPS
StockNov 24May 26Return
Ming Shing Group Ho… (MSW)10028.4-71.6%
Cango Inc. (CANG)10031.5-68.5%
Autolus Therapeutic… (AUTL)10047.3-52.7%
CLPS Incorporation (CLPS)10081.1-18.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: MSW vs CANG vs AUTL vs CLPS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CLPS leads in 3 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Autolus Therapeutics plc is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. CANG also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
MSW
Ming Shing Group Holdings Limited
The Growth Angle

MSW lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: industrials exposure
CANG
Cango Inc.
The Long-Run Compounder

CANG is the clearest fit if your priority is long-term compounding.

  • -44.9% 10Y total return vs MSW's -65.5%
  • -2.3% ROA vs MSW's -45.3%, ROIC 4.6% vs -52.1%
Best for: long-term compounding
AUTL
Autolus Therapeutics plc
The Growth Play

AUTL is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 496.0%, EPS growth 27.5%, 3Y rev CAGR 88.7%
  • 496.0% revenue growth vs CANG's -52.7%
  • +30.5% vs CANG's -73.7%
Best for: growth exposure
CLPS
CLPS Incorporation
The Income Pick

CLPS carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 3 yrs, beta 0.27, yield 14.6%
  • Lower volatility, beta 0.27, Low D/E 58.8%, current ratio 1.58x
  • Beta 0.27, yield 14.6%, current ratio 1.58x
  • -1.3% margin vs AUTL's -439.7%
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthAUTL logoAUTL496.0% revenue growth vs CANG's -52.7%
Quality / MarginsCLPS logoCLPS-1.3% margin vs AUTL's -439.7%
Stability / SafetyCLPS logoCLPSBeta 0.27 vs CANG's 2.25
DividendsCLPS logoCLPS14.6% yield; 3-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)AUTL logoAUTL+30.5% vs CANG's -73.7%
Efficiency (ROA)CANG logoCANG-2.3% ROA vs MSW's -45.3%, ROIC 4.6% vs -52.1%

MSW vs CANG vs AUTL vs CLPS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MSWMing Shing Group Holdings Limited
FY 2025
Private
66.7%$23M
Public
33.3%$11M
CANGCango Inc.
FY 2024
After-market Service Facilitation Service Income
62.9%$41M
Loan Facilitation Income And Other Related Income
24.1%$16M
Automobile trading income
9.6%$6M
Service, Other
3.4%$2M
AUTLAutolus Therapeutics plc
FY 2024
License
100.0%$10M
CLPSCLPS Incorporation
FY 2025
Other Member
100.0%$894,598

MSW vs CANG vs AUTL vs CLPS — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCANGLAGGINGCLPS

Income & Cash Flow (Last 12 Months)

Evenly matched — CANG and CLPS each lead in 3 of 6 comparable metrics.

CANG is the larger business by revenue, generating $3.5B annually — 102.2x MSW's $34M. Profitability is closely matched — net margins range from -1.3% (CLPS) to -4.4% (AUTL). On growth, CANG holds the edge at +58.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMSW logoMSWMing Shing Group …CANG logoCANGCango Inc.AUTL logoAUTLAutolus Therapeut…CLPS logoCLPSCLPS Incorporation
RevenueTrailing 12 months$34M$3.5B$51M$299M
EBITDAEarnings before interest/tax$333M-$427M-$1M
Net IncomeAfter-tax profit-$178M-$225M-$4M
Free Cash FlowCash after capex$0-$278M$0
Gross MarginGross profit ÷ Revenue-3.9%+13.6%-3.1%+22.8%
Operating MarginEBIT ÷ Revenue-15.8%+7.3%-8.6%-1.4%
Net MarginNet income ÷ Revenue-16.9%-5.2%-4.4%-1.3%
FCF MarginFCF ÷ Revenue-23.5%-154.0%-5.4%-2.3%
Rev. Growth (YoY)Latest quarter vs prior year+58.3%+15.3%
EPS Growth (YoY)Latest quarter vs prior year+3.6%+3.2%+75.8%
Evenly matched — CANG and CLPS each lead in 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — MSW and CANG and CLPS each lead in 1 of 3 comparable metrics.
MetricMSW logoMSWMing Shing Group …CANG logoCANGCango Inc.AUTL logoAUTLAutolus Therapeut…CLPS logoCLPSCLPS Incorporation
Market CapShares × price$25M$250M$410M$25M
Enterprise ValueMkt cap + debt − cash$33M$85M$235M$31M
Trailing P/EPrice ÷ TTM EPS-4.02x5.66x-1.84x-3.48x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple3.13x
Price / SalesMarket cap ÷ Revenue0.74x2.12x40.47x0.15x
Price / BookPrice ÷ Book value/share23.24x0.42x0.96x0.43x
Price / FCFMarket cap ÷ FCF
Evenly matched — MSW and CANG and CLPS each lead in 1 of 3 comparable metrics.

Profitability & Efficiency

CANG leads this category, winning 7 of 9 comparable metrics.

CANG delivers a -4.1% return on equity — every $100 of shareholder capital generates $-4 in annual profit, vs $-6 for MSW. CANG carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to MSW's 7.87x. On the Piotroski fundamental quality scale (0–9), AUTL scores 5/9 vs CLPS's 2/9, reflecting solid financial health.

MetricMSW logoMSWMing Shing Group …CANG logoCANGCango Inc.AUTL logoAUTLAutolus Therapeut…CLPS logoCLPSCLPS Incorporation
ROE (TTM)Return on equity-5.8%-4.1%-84.7%-6.1%
ROA (TTM)Return on assets-45.3%-2.3%-34.0%-3.2%
ROICReturn on invested capital-52.1%+4.6%-2.0%-7.9%
ROCEReturn on capital employed-133.1%+4.5%-45.9%-9.8%
Piotroski ScoreFundamental quality 0–93452
Debt / EquityFinancial leverage7.87x0.04x0.12x0.59x
Net DebtTotal debt minus cash$7M-$1.1B-$175M$6M
Cash & Equiv.Liquid assets$249,923$1.3B$227M$28M
Total DebtShort + long-term debt$8M$170M$53M$34M
Interest CoverageEBIT ÷ Interest expense-10.52x-1.87x-25.98x
CANG leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CANG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CANG five years ago would be worth $8,579 today (with dividends reinvested), compared to $2,989 for AUTL. Over the past 12 months, AUTL leads with a +30.5% total return vs CANG's -73.7%. The 3-year compound annual growth rate (CAGR) favors CANG at 0.4% vs MSW's -29.8% — a key indicator of consistent wealth creation.

MetricMSW logoMSWMing Shing Group …CANG logoCANGCango Inc.AUTL logoAUTLAutolus Therapeut…CLPS logoCLPSCLPS Incorporation
YTD ReturnYear-to-date+93.2%-62.0%-14.2%-10.3%
1-Year ReturnPast 12 months-40.6%-73.7%+30.5%-5.4%
3-Year ReturnCumulative with dividends-65.5%+1.2%-14.6%+0.5%
5-Year ReturnCumulative with dividends-65.5%-14.2%-70.1%-69.3%
10-Year ReturnCumulative with dividends-65.5%-44.9%-93.6%-78.5%
CAGR (3Y)Annualised 3-year return-29.8%+0.4%-5.1%+0.2%
CANG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — AUTL and CLPS each lead in 1 of 2 comparable metrics.

CLPS is the less volatile stock with a 0.27 beta — it tends to amplify market swings less than CANG's 2.25 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AUTL currently trades 59.4% from its 52-week high vs CANG's 18.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMSW logoMSWMing Shing Group …CANG logoCANGCango Inc.AUTL logoAUTLAutolus Therapeut…CLPS logoCLPSCLPS Incorporation
Beta (5Y)Sensitivity to S&P 5001.15x2.49x1.87x0.19x
52-Week HighHighest price in past year$8.11$2.88$2.70$1.88
52-Week LowLowest price in past year$0.60$0.33$1.15$0.80
% of 52W HighCurrent price vs 52-week peak+23.8%+18.6%+59.4%+48.2%
RSI (14)Momentum oscillator 0–10061.558.664.349.8
Avg Volume (50D)Average daily shares traded77K1.3M1.6M15K
Evenly matched — AUTL and CLPS each lead in 1 of 2 comparable metrics.

Analyst Outlook

CANG leads this category, winning 1 of 1 comparable metric.

Analyst consensus: CANG as "Buy", AUTL as "Buy". Consensus price targets imply 459.2% upside for CANG (target: $3) vs 452.6% for AUTL (target: $9). CLPS is the only dividend payer here at 14.60% yield — a key consideration for income-focused portfolios.

MetricMSW logoMSWMing Shing Group …CANG logoCANGCango Inc.AUTL logoAUTLAutolus Therapeut…CLPS logoCLPSCLPS Incorporation
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$3.00$8.87
# AnalystsCovering analysts214
Dividend YieldAnnual dividend ÷ price+14.6%
Dividend StreakConsecutive years of raises53
Dividend / ShareAnnual DPS$0.13
Buyback YieldShare repurchases ÷ mkt cap0.0%+5.3%0.0%0.0%
CANG leads this category, winning 1 of 1 comparable metric.
Key Takeaway

CANG leads in 3 of 6 categories — strongest in Profitability & Efficiency and Total Returns. 3 categories are tied.

Best OverallCango Inc. (CANG)Leads 3 of 6 categories
Loading custom metrics...

MSW vs CANG vs AUTL vs CLPS: Key Questions Answered

8 questions · data-driven answers · updated daily

01

Is MSW or CANG or AUTL or CLPS a better buy right now?

For growth investors, Autolus Therapeutics plc (AUTL) is the stronger pick with 496.

0% revenue growth year-over-year, versus -52. 7% for Cango Inc. (CANG). Cango Inc. (CANG) offers the better valuation at 5. 7x trailing P/E, making it the more compelling value choice. Analysts rate Cango Inc. (CANG) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — MSW or CANG or AUTL or CLPS?

Over the past 5 years, Cango Inc.

(CANG) delivered a total return of -14. 2%, compared to -70. 1% for Autolus Therapeutics plc (AUTL). Over 10 years, the gap is even starker: CANG returned -43. 2% versus AUTL's -93. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — MSW or CANG or AUTL or CLPS?

By beta (market sensitivity over 5 years), CLPS Incorporation (CLPS) is the lower-risk stock at 0.

19β versus Cango Inc. 's 2. 49β — meaning CANG is approximately 1177% more volatile than CLPS relative to the S&P 500. On balance sheet safety, Cango Inc. (CANG) carries a lower debt/equity ratio of 4% versus 8% for Ming Shing Group Holdings Limited — giving it more financial flexibility in a downturn.

04

Which is growing faster — MSW or CANG or AUTL or CLPS?

By revenue growth (latest reported year), Autolus Therapeutics plc (AUTL) is pulling ahead at 496.

0% versus -52. 7% for Cango Inc. (CANG). On earnings-per-share growth, the picture is similar: Cango Inc. grew EPS 960. 0% year-over-year, compared to -400. 0% for Ming Shing Group Holdings Limited. Over a 3-year CAGR, AUTL leads at 88. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — MSW or CANG or AUTL or CLPS?

Cango Inc.

(CANG) is the more profitable company, earning 37. 3% net margin versus -21. 8% for Autolus Therapeutics plc — meaning it keeps 37. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CANG leads at 22. 2% versus -23. 9% for AUTL. At the gross margin level — before operating expenses — CANG leads at 55. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — MSW or CANG or AUTL or CLPS?

In this comparison, CLPS (14.

6% yield) pays a dividend. MSW, CANG, AUTL do not pay a meaningful dividend and should not be held primarily for income.

07

Is MSW or CANG or AUTL or CLPS better for a retirement portfolio?

For long-horizon retirement investors, CLPS Incorporation (CLPS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

19), 14. 6% yield). Cango Inc. (CANG) carries a higher beta of 2. 49 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CLPS: -78. 6%, CANG: -43. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between MSW and CANG and AUTL and CLPS?

These companies operate in different sectors (MSW (Industrials) and CANG (Consumer Cyclical) and AUTL (Healthcare) and CLPS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MSW is a small-cap high-growth stock; CANG is a small-cap deep-value stock; AUTL is a small-cap high-growth stock; CLPS is a small-cap high-growth stock. CLPS pays a dividend while MSW, CANG, AUTL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

MSW

High-Growth Disruptor

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 11%
Run This Screen
Stocks Like

CANG

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 2916%
Run This Screen
Stocks Like

AUTL

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 247%
Run This Screen
Stocks Like

CLPS

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 13%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MSW and CANG and AUTL and CLPS on the metrics below

Revenue Growth>
%
(MSW: 22.8% · CANG: 5833.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.